NANCY BOSSE: Open Payments
NPI 1952607558 · WESTMORELAND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 21 payments from 11 companies in 2025. Trend: 2023 $232 · 2024 $59 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $125 |
| PFIZER INC. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Melinta Therapeutics, LLC | 2 | $44 |
| Lilly USA, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| Verona Pharma, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: CAPLYTA, PREVNAR 20, EOHILIA, Kimyrsa, MOUNJARO, Dexcom G6 Transmitter, LEQVIO, INFINITY.
Industry payments across KS — which companies pay providers there.
